Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
- Linda L. Humphrey, MD, MPH;
- Mark Helfand, MD, MS;
- Benjamin K.S. Chan, MS; and
- Steven H. Woolf, MD, MPH
-
From Oregon Health & Science University and Portland Veterans Affairs Medical Center, Portland, Oregon; and Medical College
of Virginia, Virginia Commonwealth University, Fairfax, Virginia.
-
Figure. Estimated curves are from a hierarchical meta-regression model. Dotted curves represent 95% credible intervals. Relative risk compared with average years of follow-up for women 40 to 49 years of age, women 50 to 74 years of age, and all
women.
-
Appendix (Figure 1). Trials of mammography link screening to health outcomes, but do not address the intermediate steps (screening
and early treatment) or harms (adverse effects of screening and early treatment). Arrows indicating screening and early treatment
represent the intermediate steps in the causal chain linking screening with improved mortality and morbidity. Analytic framework.
-
Appendix (Figure 2). Selection of randomized trials for the systematic review and meta-analysis.
- Copyright ©2004 by the American College of Physicians
-
Ann Intern Med
September 3, 2002
vol. 137
no. 5 Part 1
347-360